Samsung Biologics
삼성바이오로직스KRX: 207940· Fiscal year 2025· samsungbiologics.com ↗
Average salary
$83.9K
₩111.7M
▲ 9.4% vs 2024
Employees
5,455
▲ 8.9% vs 2024
Average tenure
4.9 yrs
Estimated take-home of this pay:$5.4K / monthCalculate →
Workplace
Women's pay (men = 100)88
Women among staff44.5%
Contract staff4.8%
Recent official filings
- 2026-11-17MajorShare issuance result
- 2026-11-16Quarterly report (2026.09)
- 2026-11-16MajorShare issuance result
- 2026-11-11MajorShare issuance result
- 2026-11-05MajorNew share issue (capital raise)
- 2026-11-03Supply contract signed
Quick read
- Average pay is 83% above the median of the companies we track.
- Average pay rose 9.4% from 2024.
- Headcount grew by 444 (8.9%) from 2024.
- Ranks #8 of 238 Healthcare & Pharma companies in this country by pay.
- Revenue grew 30.3% year over year.
- Revenue has grown two years in a row.
- Operating margin was 45.4% in 2025.
Last 3 years
Revenue
Operating income
See the share price on Naver Finance ↗
Investor metrics
2025
- Revenue per employee
- $625.5K
- Net profit per employee
- $244.9K
- Operating margin
- 45.4%
- Net margin
- 39.2%
- ROE
- 23.9%
- Debt-to-equity
- 48.4%
- Equity ratio
- 67.4%
Per-employee figures use the company headcount, so they run high for groups with many subsidiaries. Not investment advice.